⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Pulmonary Edema (2026-2031) - Rising Prevalence of Cardiovascular Diseases Drives Market Growth
globenewswire.com
ABBV
AZN
BSX
BMY
EL
LLY
JNJ
MRK
NVS
PFE
SNY
VTRS
Upper Respiratory Tract Infection Treatment (2026-2031) - Rising Prevalence of Respiratory Infections Drives Market Growth
globenewswire.com
ABT
ABBV
ALC
AZN
BMY
CI
DDS
JNJ
MRK
NVS
PFE
SNY
TEVA
VTRS
AI Disrupts Topical Drug Delivery as Billion-Dollar Partnerships and $3.3 Billion in VC Funding Signal a Structural Shift in Pharmaceutical Formulation
globenewswire.com
LLY
RXRX
NVDA
NVS
SNY
SPRY
Active Pharmaceutical Ingredients (API) Market Report 2026-2036 Just Released — Analyses Synthetic, Biotech, Traditional and Highly Potent APIs
globenewswire.com
MRK
PFE
NVS
Kynexis Extends Series A to €97 Million to Advance Potential First-in-Class Investigational Medicine for Cognitive Disorders
globenewswire.com
NVS
Vulvar Cancer Therapeutics Market Share Analysis, Trends and Growth Forecast 2026-2031
globenewswire.com
ABBV
AMGN
AZN
BMY
LLY
GSK
JNJ
MRK
NVS
PDSB
PFE
SNY
Novartis data at ESC Congress 2026 reinforce cardiovascular leadership and showcase progress in next-generation therapies
globenewswire.com
NVS
Trends & Strategies in the $4.3 Billion Soft Tissue Sarcoma Market, 2026-2031
globenewswire.com
AZN
BMY
LLY
GSK
ILMN
MRK
NVS
PFE
QGEN
SNY
VTRS
OncoOne Establishes Scientific Advisory Board to Support its Modular PreTarg-it® Platform for Radionuclide Therapies
businesswire.com
TLX
BIIB
NVS
BMY
Registration Open for 3-Day "Pharmaceutical Packaging Essentials: From Regulatory Compliance to Market Success" Virtual Seminar (Jan 25th - Jan 27th, 2027)
globenewswire.com
GSK
NVS